Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Darbepoetin alfa 500, Myelodysplastic Syndrome

Protocol-ID: 837 V1.0 (Mini), DARB500, MDS

Indication(s)

  • Myelodysplastic Neoplasms; ICD-10 D46.-

Links

  • ARCADE (20090160): A phase 3 randomized placebo-controlled double-blind trial of Darbepoetin alfa in the treatment of anemia in patients with low or intermediate-1 risk myelodyplastic syndromes (MDS) [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 13.02.2017